CLINICAL PATHWAYS FOR ACUTE CARE IN TASMANIAN EMERGENCY DEPARTMENTS
With Associate Professor Viet Tran, Deputy Director of Emergency Medicine at Royal Hobart Hospital & Founding Director, Tasmanian Emergency Medicine Research Institute & Emergency Medicine Discipline Lead, University of Tasmania, Tasmania, Australia
RESEARCHER PROFILE
Filmed in Hobart, Australia | July 2025
Viet Tran is Associate Professor of Emergency Medicine at the University of Tasmania, Founding Director of the Tasmanian Emergency Medicine Research Institute, Deputy Director of Emergency Medicine at Royal Hobart Hospital, Chair of the Tasmanian Emergency Departments Network and Inaugural Co-Chair of the Tasmanian Health Senate.
A/Prof Tran also works at the coalface of healthcare as an Emergency Physician and continually advocates for excellence in patient care through education, research, quality and safety and health reform.
He has built Emergency Medicine Research in Tasmania from the ground up, which has culminated in the success of a AUD$3 million Australian Government Medical Research Futures Fund grant looking into the Implementation of Clinical Pathways for Acute Care in Tasmania project. Dr Tran is also the Emergency Medicine Discipline lead within the Tasmanian School of Medicine and has key roles to play within Emergency Medicine training. He feels privileged to be able to teach and mentor across the whole spectrum of becoming a doctor, from watching students grow into junior doctors, senior registrar and as fellow medical specialists.
Source: University of Tasmania website
-
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
-
Impact of Leukaemia Foundation’s Research Funding into Blood Cancer
Bill Stavreski is the Head of Research at the Leukaemia Foundation who talks about the research impact in recent years. The Foundation itself marks its 25th anniversary in 2025, having funded a wide range of health and medical research since 2000. With a focus on basic science, health services research, treatment, and care, the organisation has invested nearly $90 million (adjusted in current dollars terms) in approximately 370 research grants over the years.
-
Systems genetics to determine risk of developing diabetes complications
Professor Morahan invented the term “Systems Genetics” for the science field that examines how genetic variants can affect whole networks of genes and whole systems; there are now several laboratories and institutes of systems genetics around the world. He also developed the next-generation genetic resource, The Gene Mine, the most powerful of its type in the world, used globally in rapid mapping and identification of genes. Collaborators nationally and internationally have tested The Gene Mine for traits and diseases in which they specialise.
